Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells

被引:7
|
作者
Klaihmon, Phatchanat [1 ]
Kang, Xing [1 ]
Issaragrisil, Surapol [1 ,2 ,3 ]
Luanpitpong, Sudjit [1 ,4 ]
机构
[1] Mahidol Univ, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Siriraj Hosp, Bangkok 10700, Thailand
[2] Mahidol Univ, Fac Med, Dept Med, Div Hematol,Siriraj Hosp, Bangkok 10700, Thailand
[3] Wattanosoth Canc Hosp, BDMS Ctr Excellence Hematol, Bangkok 10310, Thailand
[4] Mahidol Univ, Fac Med, Blood Prod & Cellular Immunotherapy Res Grp, Siriraj Hosp, Bangkok 10700, Thailand
关键词
chimeric antigen receptor; induced pluripotent stem cell; natural killer cell; anti-CD19; CAR; leukemia; CAR-NK; NK differentiation; DIFFERENTIATION; CANCER; MEMORY;
D O I
10.3390/ijms241310508
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural killer (NK) cells are a part of innate immunity that can be activated rapidly in response to malignant transformed cells without prior sensitization. Engineering NK cells to express chimeric antigen receptors (CARs) allows them to be directed against corresponding target tumor antigens. CAR-NK cells are regarded as a promising candidate for cellular immunotherapy alternatives to conventional CAR-T cells, due to the relatively low risk of graft-versus-host disease and safer clinical profile. Human induced pluripotent stem cells (iPSCs) are a promising renewable cell source of clinical NK cells. In the present study, we successfully introduced a third-generation CAR targeting CD19, which was validated to have effective signaling domains suitable for NK cells, into umbilical cord blood NK-derived iPSCs, followed by a single-cell clone selection and thorough iPSC characterization. The established single-cell clone of CAR19-NK/iPSCs, which is highly desirable for clinical application, can be differentiated using serum- and feeder-free protocols into functional CAR19-iNK-like cells with improved anti-tumor activity against CD19-positive hematologic cancer cells when compared with wild-type (WT)-iNK-like cells. With the feasibility of being an alternative source for off-the-shelf CAR-NK cells, a library of single-cell clones of CAR-engineered NK/iPSCs targeting different tumor antigens may be created for future clinical application.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] The generation and functional characterization of induced pluripotent stem cells from human intervertebral disc nucleus pulposus cells
    Zhu, Yanxia
    Liang, Yuhong
    Zhu, Hongxia
    Lian, Cuihong
    Wang, Liang
    Wang, Yiwei
    Gu, Hongsheng
    Zhou, Guangqian
    Yu, Xiaoping
    ONCOTARGET, 2017, 8 (26) : 42700 - 42711
  • [42] Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
    An, Na
    Tao, Zhongfei
    Li, Saisai
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    ONCOTARGET, 2016, 7 (09) : 10638 - 10649
  • [43] Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion
    Klaihmon, Phatchanat
    Samart, Parinya
    Rojanasakul, Yon
    Issaragrisil, Surapol
    Luanpitpong, Sudjit
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [44] Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
    Benabdallah, Basma
    Desaulniers-Langevin, Cynthia
    Colas, Chloe
    Li, Yuanyi
    Rousseau, Guy
    Guimond, Jean V.
    Haddad, Elie
    Beausejour, Christian
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [45] Increased Telomere Length in Natural Killer Cells Generated from Human Induced Pluripotent Stem Cells
    Scaria, George
    Argall, Trevor
    Bendzick, Laura
    Kaufman, Dan S.
    BLOOD, 2014, 124 (21)
  • [46] Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
    Mancikova, Veronika
    Peschelova, Helena
    Kozlova, Veronika
    Ledererova, Aneta
    Ladungova, Adriana
    Verner, Jan
    Loja, Tomas
    Folber, Frantisek
    Mayer, Jiri
    Pospisilova, Sarka
    Smida, Michal
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [47] Generation and Characterization of Erythroid Cells from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells: An Overview
    Chang, Kai-Hsin
    Bonig, Halvard
    Papayannopoulou, Thalia
    STEM CELLS INTERNATIONAL, 2011, 2011
  • [48] Efficient generation of endothelial cells from human pluripotent stem cells and characterization of their functional properties
    Song, Wei
    Kaufman, Dan S.
    Shen, Wei
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2016, 104 (03) : 678 - 687
  • [49] Generation of CD19-Targeted Chimeric Antigen Receptor T Cells
    Kiani, Jafar
    Naderi, Mahmood
    Torabi-Rahvar, Monireh
    Ranjbar, Azam
    Aghayan, Hamid-Reza
    Janzamin, Ehsan
    Ahmadbeigi, Naser
    ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (01) : 7 - 10
  • [50] Generation of Functional Human Hepatic Endoderm from Human Induced Pluripotent Stem Cells
    Sullivan, Gareth J.
    Hay, David C.
    Park, In-Hyun
    Fletcher, Judy
    Hannoun, Zara
    Payne, Catherine M.
    Dalgetty, Donna
    Black, James R.
    Ross, James A.
    Samuel, Kay
    Wang, Gang
    Daley, George Q.
    Lee, Je-Hyuk
    Church, George M.
    Forbes, Stuart J.
    Iredale, John P.
    Wilmut, Ian
    HEPATOLOGY, 2010, 51 (01) : 329 - 335